Reducing usage in the ‘Painkiller Capital’ of the UK How one CCG managed to reduce the number of prescriptions for painkillers 2 comments Exposing the Brexit campaign's NHS promises Elation or devastation—Friday 24 June was a day that British people are not likely to forget. I was broken-hearted. Knell tolls for Hunt and homeopathy Replacing scientifically verified vaccinations and treatments for 'bonkers' homeopathic medicine is dangerous. But not as dangerous as the health secretary who champions such treatments, writes Abigail James Healthcare's male bias hurts women Healthcare trials are still guilty of exhibiting gender inequaility and need to adapt to address the anatomical and physiological differences between men and women writes Abigail James. Pharmacists' role in community health Last week I had the pleasure of meeting community pharmacists at a seminar. It was a delight to hear about initiatives which are having a real impact on the health of individuals and communities. Addressing antibiotic resistance Antibiotics are one of the most relied on tools in modern healthcare. Without the protection they confer, a host of commonplace infections could not be treated and procedures would not be able to take place. We must remain vigilant on meningitis Receiving a 'positive opinion' from the Committee for Medical Products for Bexsero, a new vaccine to protect against meningococcal group B disease (MenB), is probably the most significant step forward in the fight against meningitis in a decade. Let us build on our immunisation success This month marks 20 years since, as health secretary, I signed off the introduction of a vaccination programme in the UK against invasive Haemophilus influenza type b (Hib). The anniversary allows us to reflect on the success of childhood immunisation pro Regulation is needed for off-label drugs The GMC is currently revising its guidelines, in part to enable health professionals to prescribe off-label or unlicensed medicines on the basis of cost. While the council is thought to have stepped back from its original proposal to abandon the need to i
Reducing usage in the ‘Painkiller Capital’ of the UK How one CCG managed to reduce the number of prescriptions for painkillers 2 comments
Exposing the Brexit campaign's NHS promises Elation or devastation—Friday 24 June was a day that British people are not likely to forget. I was broken-hearted.
Knell tolls for Hunt and homeopathy Replacing scientifically verified vaccinations and treatments for 'bonkers' homeopathic medicine is dangerous. But not as dangerous as the health secretary who champions such treatments, writes Abigail James
Healthcare's male bias hurts women Healthcare trials are still guilty of exhibiting gender inequaility and need to adapt to address the anatomical and physiological differences between men and women writes Abigail James.
Pharmacists' role in community health Last week I had the pleasure of meeting community pharmacists at a seminar. It was a delight to hear about initiatives which are having a real impact on the health of individuals and communities.
Addressing antibiotic resistance Antibiotics are one of the most relied on tools in modern healthcare. Without the protection they confer, a host of commonplace infections could not be treated and procedures would not be able to take place.
We must remain vigilant on meningitis Receiving a 'positive opinion' from the Committee for Medical Products for Bexsero, a new vaccine to protect against meningococcal group B disease (MenB), is probably the most significant step forward in the fight against meningitis in a decade.
Let us build on our immunisation success This month marks 20 years since, as health secretary, I signed off the introduction of a vaccination programme in the UK against invasive Haemophilus influenza type b (Hib). The anniversary allows us to reflect on the success of childhood immunisation pro
Regulation is needed for off-label drugs The GMC is currently revising its guidelines, in part to enable health professionals to prescribe off-label or unlicensed medicines on the basis of cost. While the council is thought to have stepped back from its original proposal to abandon the need to i